New Weight-Loss Drug Mounjaro Shows Promise in Preventing Diabetes

Eli Lilly’s weight-loss drug, tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight loss), has shown promising results in preventing the onset of type 2 diabetes, even after patients stopped taking the medication. A three-year study found that individuals…